The Wegovy maker’s once-daily pill to treat type 2 diabetes has shown it cuts the risk of heart attacks and strokes in patients by up to 14%, according to a new trial.
Related Posts
Intuit Maintains Full Year Guidance; CEO Says Trump Administration Won’t Build Tax-Filing App
President-elect Donald Trump’s incoming administration doesn’t “want to add to the bureaucracy and they don’t want to add investments to create something…that already exists,” said […]
Toyota Motor Cuts Sales Forecast After Quarterly Profit Halves
The Japanese auto giant cut its annual forecast for group vehicle sales after its second-quarter profit more than halved due partly to weaker sales globally.
Deutsche Bank Warns of Hit From Commercial Real Estate Exposure
Deutsche Bank increased its forecast for full-year credit losses, warning that it expected continued pressure from exposure to commercial real estate, at a time a […]